Vimentin is associated with poor prognoses and invasion of breast cancer, bladder cancer, esophageal cancer, lung cancer, and other cancers, and it is a potential target for cancer treatment [39–42]. The gene discussed is VIM; the disease is urinary bladder carcinoma.